Ars Pharmaceuticals, Inc.
SPRY
Revenue
500.00k
▲500.00k∞%
3 Months ChangeAssets
221.97M
▼-5.62M▼-2.47%
3 Months ChangeLiabilities
6.73M
▲3.01M▲81.02%
3 Months ChangeFree Cash Flow
-6.79M
▲5.83M▲46.18%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001193125-24-237191
2024-09-23
Form 8-K
ID: 0001193125-24-223676
2024-08-12
Form 8-K
ID: 0001193125-24-198384
2024-08-06
Form 10-Q
ID: 0000950170-24-091776
2024-08-06
Form 8-K
ID: 0000950170-24-091745
2024-06-28
Form 8-K
ID: 0001193125-24-172166
2024-06-28
Form 8-K
ID: 0001193125-24-171204
2024-06-21
Form 8-K
ID: 0001193125-24-165812
2024-05-10
Form 8-K
ID: 0001193125-24-135721
2024-05-09
Form 10-Q
ID: 0000950170-24-056967